Literature DB >> 33764395

The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making.

Donna Przepiorka1, R Angelo de Claro1, Richard Pazdur1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33764395     DOI： 10.1001/jamaoncol.2021.0122

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  1 in total

1.  Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis.

Authors:  Nicholas J Short; Chenqi Fu; Donald A Berry; Roland B Walter; Sylvie D Freeman; Christopher S Hourigan; Xuelin Huang; Graciela Nogueras Gonzalez; Hyunsoo Hwang; Xinyue Qi; Hagop Kantarjian; Shouhao Zhou; Farhad Ravandi
Journal:  Leukemia       Date:  2022-10-19       Impact factor: 12.883
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.